Amdocs Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Amdocs stock.
View analyst ratings for Amdocs or view top-rated stocks.

2 equities research analysts have issued 1 year price objectives for Amdocs' stock. Their DOX stock forecasts range from $86.00 to $99.00. On average, they expect Amdocs' share price to reach $91.67 in the next year. This suggests a possible upside of 8.3% from the stock's current price.
View analysts' price targets for Amdocs or view top-rated stocks among Wall Street analysts.

Amdocs' stock was trading at $74.84 at the beginning of the year. Since then, DOX stock has increased by 13.1% and is now trading at $84.68.
View the best growth stocks for 2022 here.

Amdocs saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 1,820,000 shares, a decrease of 17.6% from the May 15th total of 2,210,000 shares. Based on an average daily volume of 645,700 shares, the short-interest ratio is presently 2.8 days. Approximately 1.5% of the shares of the stock are short sold.
View Amdocs' Short Interest.

Amdocs is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Amdocs.

Amdocs Limited (NASDAQ:DOX) issued its quarterly earnings data on Wednesday, May, 11th. The technology company reported $1.43 EPS for the quarter, beating the consensus estimate of $1.12 by $0.31. The technology company earned $1.15 billion during the quarter, compared to the consensus estimate of $1.12 billion. Amdocs had a trailing twelve-month return on equity of 16.78% and a net margin of 12.76%. During the same period in the previous year, the firm earned $1.05 EPS.
View Amdocs' earnings history.

Amdocs announced a quarterly dividend on Wednesday, May 11th. Stockholders of record on Thursday, June 30th will be given a dividend of $0.395 per share on Friday, July 29th. This represents a $1.58 annualized dividend and a yield of 1.87%. The ex-dividend date of this dividend is Wednesday, June 29th.
View Amdocs' dividend history.

Amdocs(NASDAQ:DOX) pays an annual dividend of $1.58 per share and currently has a dividend yield of 1.86%. Amdocs has been increasing its dividend for 9 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Amdocs is 35.43%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Amdocs will have a dividend payout ratio of 28.83% next year. This indicates that Amdocs will be able to sustain or increase its dividend.
View Amdocs' dividend history.

Amdocs issued an update on its third quarter 2022 earnings guidance on Wednesday, June, 8th. The company provided EPS guidance of $1.23-$1.29 for the period, compared to the consensus EPS estimate of $1.30. The company issued revenue guidance of $1.14 billion-$1.18 billion, compared to the consensus revenue estimate of $1.09 billion.

915 employees have rated Amdocs CEO Shuky Sheffer on Glassdoor.com. Shuky Sheffer has an approval rating of 90% among Amdocs' employees.

Some companies that are related to Amdocs include Accenture (ACN), International Business Machines (IBM), Cognizant Technology Solutions (CTSH), Gartner (IT), EPAM Systems (EPAM), Leidos (LDOS), Booz Allen Hamilton (BAH), CACI International (CACI), Teradata (TDC), ManTech International (MANT), Forrester Research (FORR), Unisys (UIS), The Hackett Group (HCKT) and ServiceSource International (SREV).
View all of DOX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include Home Depot (HD), Pfizer (PFE), AT&T (T), NVIDIA (NVDA), Exxon Mobil (XOM), AbbVie (ABBV), International Business Machines (IBM), Johnson & Johnson (JNJ), Advanced Micro Devices (AMD) and Comcast (CMCSA).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (5.15%), Pzena Investment Management LLC (4.96%), LSV Asset Management (3.59%), Beutel Goodman & Co Ltd. (3.31%), BlackRock Inc. (3.08%) and Nordea Investment Management AB (2.13%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Nordea Investment Management AB, Bank of America Corp DE, Qube Research & Technologies Ltd, LSV Asset Management, Neuberger Berman Group LLC, UNIVEST FINANCIAL Corp, and Beutel Goodman & Co Ltd..

DOX stock was acquired by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Pzena Investment Management LLC, Ardevora Asset Management LLP, American Century Companies Inc., Massachusetts Financial Services Co. MA, abrdn plc, Brandes Investment Partners LP, and Boston Trust Walden Corp.

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DOX stock can currently be purchased for approximately $84.68.

Amdocs (NASDAQ:DOX) has a market capitalization of $11.10 billion and generates $4.29 billion in revenue each year. The technology company earns $688.37 million in net income (profit) each year or $4.46 on an earnings per share basis.

Amdocs employs 27,176 workers across the globe.

Amdocs was founded in 1982.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The official website for Amdocs is www.amdocs.com. The technology company can be reached via phone at (314) 212-7000, via email at [email protected], or via fax at 1 314 212 7500.